Lucid Diagnostics Inc.
(LUCD)
undefined
undefined%
At close: undefined
0.76
-2.91%
After-hours Dec 13, 2024, 05:49 PM EST
Company Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company.
The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device.
The company was incorporated in 2018 and is based in New York, New York.
Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Lucid Diagnostics Inc.
| Country | United States |
| IPO Date | Oct 14, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 70 |
| CEO | Dr. Lishan Aklog M.D. |
Contact Details
Address: One Grand Central Place New York, New York United States | |
| Website | https://www.luciddx.com |
Stock Details
| Ticker Symbol | LUCD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001799011 |
| CUSIP Number | 54948X109 |
| ISIN Number | US54948X1090 |
| Employer ID | 82-5488042 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Lishan Aklog M.D. | Chairman & Chief Executive Officer |
| Dennis M. McGrath CPA | Chief Financial Officer |
| Richard D. Yazbeck | Chief Technology Officer |
| Shaun M. O'Neill M.B.A. | President & Chief Operating Officer |
| Dr. Amitabh Chak M.D. | Co-Founder, Strategic Advisor & Member of Medical Advisory Board |
| Dr. Joseph Willis M.D. | Cofounder, Strategic Advisor & Member of Medical Advisory Board |
| Dr. Sanford D. Markowitz M.D., Ph.D. | Co-Founder, Strategic Advisor & Member of the Medical Advisor Board |
| Dr. Suman M. Verma M.D., Ph.D. | Chief Scientific Officer |
| Matthew Riley | Director of Investor Relations |
| Michael Adam Gordon | General Counsel & Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 12, 2024 | SC 13D/A | [Amend] Filing |
| Dec 06, 2024 | D | Filing |
| Nov 29, 2024 | 8-K | Current Report |
| Nov 18, 2024 | 8-K | Current Report |
| Nov 13, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Aug 12, 2024 | 10-Q | Quarterly Report |
| Aug 12, 2024 | 8-K | Current Report |
| Jul 24, 2024 | 8-K | Current Report |